These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 5288356)

  • 1. Thromboplastic activity of leukaemic eosinophils.
    Lisiewicz J; Okulski J
    Haematologia (Budap); 1970; 4(2):213-20. PubMed ID: 5288356
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effect of acridine dyes on heparin activity and blood coagulation].
    Berge H
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1971; 95(4):419-25. PubMed ID: 4107578
    [No Abstract]   [Full Text] [Related]  

  • 3. On the influence of normal and leukemic human leukocytes on blood coagulation.
    Lisiewicz J; Astaldi G; Okulski J; Merolla R
    Acta Haematol; 1970; 44(6):332-40. PubMed ID: 4996387
    [No Abstract]   [Full Text] [Related]  

  • 4. Basic aspects of blood clotting: thrombokinase and cofactors in the conversion of prothrombin to thrombin.
    Ferguson JH; Ennis EG; Latridis PG; White NB
    Thromb Diath Haemorrh; 1967 Dec; 18(3-4):647-63. PubMed ID: 5590251
    [No Abstract]   [Full Text] [Related]  

  • 5. [Thromboplastic activity of the eosinophils in eosinophilic leukemia].
    Malkiewicz B; Pajdak W; Okulski J; Lisiewicz J
    Haematologia (Budap); 1971; 5(4):439-46. PubMed ID: 5148967
    [No Abstract]   [Full Text] [Related]  

  • 6. [Comparative effect of leukocytes from healthy persons and patients with chronic lymphadenosis and myelosis on blood coagulation].
    Kuznik BI; Kuz'menko EL
    Probl Gematol Pereliv Krovi; 1971 Jun; 16(6):32-5. PubMed ID: 5119061
    [No Abstract]   [Full Text] [Related]  

  • 7. The inhibition of the anticoagulant activity of heparin by platelets, brain phospholipids, and tissue factor.
    Ofosu FA; Cerskus AL; Hirsh J; Smith LM; Modi GJ; Blajchman MA
    Br J Haematol; 1984 Jun; 57(2):229-38. PubMed ID: 6733045
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Principles of the treatment of hypercoagulabilities with a rational anticoagulant therapy].
    Raby C
    Presse Med (1893); 1969 Jan; 77(1):17-9. PubMed ID: 5785756
    [No Abstract]   [Full Text] [Related]  

  • 9. [Blood coagulation changes in children with acute myelogenous leukemia: thrombin effect or proteolysis].
    von Kries R; Ebell W; Jürgens H; Göbel U
    Klin Padiatr; 1984; 196(3):174-7. PubMed ID: 6590923
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Saliva and blood coagulation].
    Rioboo Garcia R
    Arch Inst Farmacol Exp (Madr); 1970; 22(1-2):21-39. PubMed ID: 5538289
    [No Abstract]   [Full Text] [Related]  

  • 11. Thromboplastic activity of chronic myelogenous leukaemia granulocytes.
    Lisiewicz J; Malkiewicz-Wasowicz B; Biernacka B
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1973; 99(1):57-64. PubMed ID: 4121131
    [No Abstract]   [Full Text] [Related]  

  • 12. [Thromboplastic activity of endometrium extracts in hemorrhages during the female climacteric].
    Slunsky R
    Z Geburtshilfe Gynakol; 1970 Jun; 172(3):298-303. PubMed ID: 5516771
    [No Abstract]   [Full Text] [Related]  

  • 13. Normal values for thrombelastography (ROTEM) and selected coagulation parameters in porcine blood.
    Velik-Salchner C; Schnürer C; Fries D; Müssigang PR; Moser PL; Streif W; Kolbitsch C; Lorenz IH
    Thromb Res; 2006; 117(5):597-602. PubMed ID: 15985284
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Initial phase of blood coagulation].
    BEAUMONT JL; CAEN J; BERNARD J
    Sem Hop; 1953 Nov; 29(67):3437-42. PubMed ID: 13113308
    [No Abstract]   [Full Text] [Related]  

  • 15. The technique of measuring thrombin generation with fluorogenic substrates: 3. The effects of sample dilution.
    De Smedt E; Wagenvoord R; Coen Hemker H
    Thromb Haemost; 2009 Jan; 101(1):165-70. PubMed ID: 19132204
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Surgical hemorrhagic syndrome. Elaboration of a practical procedure of investigation and treatment in the absence of a specialized laboratory].
    Otteni JC; Boyer C; Girardel JM; Gauthier-Lafaye JP
    Anesth Analg (Paris); 1969; 26(1):89-106. PubMed ID: 5793321
    [No Abstract]   [Full Text] [Related]  

  • 17. [On coagulation inhibiting effect of proteinase inhibitors from animal organs].
    Gülzow M; Schulz K
    Z Gesamte Inn Med; 1967 Nov; 22(21):641-7. PubMed ID: 5302275
    [No Abstract]   [Full Text] [Related]  

  • 18. [Tissue factors of blood coagulation in the valvular apparatus of the heart].
    Kuznik BI; Koreshkova GI; Reĭman LF; Panteleeva AN
    Kardiologiia; 1967 Jul; 7(7):130-3. PubMed ID: 5607156
    [No Abstract]   [Full Text] [Related]  

  • 19. [The modification of the effect of trypsin on blood coagulation by natural and synthetic trypsin and thrombin inhibitors].
    Landman H; Markwardt F; Perlewitz J
    Thromb Diath Haemorrh; 1969 Dec; 22(3):552-68. PubMed ID: 5382290
    [No Abstract]   [Full Text] [Related]  

  • 20. Increased thrombin generation and fibrinogen level after therapeutic plasma transfusion: relation to bleeding.
    Schols SE; van der Meijden PE; van Oerle R; Curvers J; Heemskerk JW; van Pampus EC
    Thromb Haemost; 2008 Jan; 99(1):64-70. PubMed ID: 18217136
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.